methylprednisolone hemisuccinate has been researched along with Libman-Sacks Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ismail, G; Minzala, G | 1 |
| Barenholz, Y; Barlev, M; Koren, E; Moallem, E; Naparstek, Y; Pizov, G; Ulmansky, R | 1 |
| Chakravarty, R; Krishnan, P; Ramadas, P; Sah, B | 1 |
| Karim, S; Majithia, V | 1 |
| Al-Mutairy, M; Al-Raqum, HA; Kumari, R; Uppal, SS | 1 |
| Boghossian, SH; Isenberg, DA; Segal, AW; Snaith, ML; Wright, G | 1 |
| Cabeças, MA; Gonçalves, H; Pinto, GM; Riscado, M | 1 |
| Wofsy, D | 1 |
| Zarro, VJ | 1 |
9 other study(ies) available for methylprednisolone hemisuccinate and Libman-Sacks Disease
| Article | Year |
|---|---|
An intriguing association of Turner syndrome with severe nephrotic syndrome: searching for a diagnosis.
Topics: Adult; Chromosomes, Human, X; Cyclophosphamide; Female; Genetic Predisposition to Disease; Humans; Lupus Erythematosus, Systemic; Methylprednisolone Hemisuccinate; Nephrotic Syndrome; Treatment Outcome; Turner Syndrome | 2016 |
A liposomal steroid nano-drug for treating systemic lupus erythematosus.
Topics: Animals; Antibodies, Antinuclear; Disease Models, Animal; Drug Administration Schedule; Female; Liposomes; Lupus Erythematosus, Systemic; Methylprednisolone Hemisuccinate; Mice; Mice, Inbred MRL lpr; Nanoparticles; Treatment Outcome | 2016 |
A Rare and Fatal Case of Viral Encephalitis in an Immunocompetent Host.
Topics: Brain; Depression; Diabetes Mellitus, Type 2; Encephalitis, Viral; Fatal Outcome; Female; Foscarnet; Herpesvirus 6, Human; Humans; Hyperlipidemias; Hypertension; Hypothyroidism; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Male; Methylprednisolone Hemisuccinate; Middle Aged; Plasmapheresis; Treatment Outcome | 2017 |
Devic's syndrome as initial presentation of systemic lupus erythematosus.
Topics: Anti-Inflammatory Agents; Brain; Female; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone Hemisuccinate; Neuromyelitis Optica; Plasmapheresis; Salivary Glands; Young Adult | 2009 |
Shrinking lung syndrome as a presenting manifestation of systemic lupus erythematosus in a female Kuwaiti.
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Female; Glucocorticoids; Humans; Hydroxychloroquine; Kuwait; Lung; Lung Diseases; Lung Volume Measurements; Lupus Erythematosus, Systemic; Methylprednisolone Hemisuccinate; Radiography, Thoracic; Respiratory Function Tests; Syndrome; Treatment Outcome | 2006 |
Effect of high-dose methylprednisolone therapy on phagocyte function in systemic lupus erythematosus.
Topics: Adult; Cell Count; Cell Movement; Female; Humans; Lactoferrin; Lupus Erythematosus, Systemic; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Neutrophils; Phagocytes; Phagocytosis; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors | 1984 |
Pyoderma gangrenosum associated with systemic lupus erythematosus: response to pulse steroid therapy.
Topics: Adult; Female; Gangrene; Humans; Leg Ulcer; Lupus Erythematosus, Systemic; Methylprednisolone Hemisuccinate; Prednisone; Pyoderma | 1991 |
New approaches to treating systemic lupus erythematosus.
Topics: Animals; Antineoplastic Agents; Humans; Lupus Erythematosus, Systemic; Methylprednisolone Hemisuccinate; Plasmapheresis | 1987 |
Steroid pulse therapy.
Topics: Anemia, Aplastic; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Drug Administration Schedule; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Methylprednisolone Hemisuccinate; Purpura, Thrombocytopenic; Skin Diseases | 1986 |